PSC Aesthetics of the Plastic Surgery Center

PSC Aesthetics of the Plastic Surgery Center in Wichita, Kansas, integrates surgical expertise with medical weight loss therapies under the direction of Dr. Amy Sprole, a board-certified plastic surgeon and Fellow of the American College of Surgeons. The clinic combines traditional plastic surgery services with peptide-based weight management programs, offering patients access to both aesthetic procedures and metabolic health interventions within a single practice. Dr. Sprole's dual focus allows for coordinated treatment planning when patients seek body contouring alongside weight optimization, a clinical advantage in addressing post-weight-loss skin laxity or preparing patients for surgical candidacy through medically supervised weight reduction.

The clinic's peptide therapy program centers on two GLP-1 receptor agonists: semaglutide and tirzepatide. Semaglutide functions by mimicking the glucagon-like peptide-1 hormone to regulate appetite and insulin secretion, while tirzepatide activates both GLP-1 and GIP receptors for dual incretin effect. These medications are administered via subcutaneous injection on weekly schedules, with dosing titrated based on individual tolerance and weight loss response. PSC Aesthetics structures these programs with regular monitoring appointments to track metabolic markers, adjust dosing protocols, and address side effects such as gastrointestinal symptoms that commonly occur during initial titration phases. The integration of weight management with plastic surgery expertise allows Dr. Sprole to counsel patients on realistic timelines for combining weight loss with procedures like abdominoplasty or breast reduction, optimizing both safety and aesthetic outcomes.

Dr. Amy Sprole completed her plastic surgery training and maintains board certification through the American Board of Plastic Surgery, with FACS designation reflecting peer recognition of surgical skill and ethical practice standards. Her clinical approach emphasizes patient education throughout the treatment process, whether explaining injection techniques for neuromodulators like Botox, discussing incision placement for reconstructive procedures, or outlining the physiological mechanisms behind peptide-induced weight loss. The clinic's nursing staff includes trained injectors who perform dermal filler treatments and administer peptide injections under Dr. Sprole's protocols, ensuring continuity between aesthetic injectables and weight management therapies. This collaborative model allows patients to receive Botox or filler treatments during the same visit as peptide therapy check-ins, streamlining care for those pursuing multiple aesthetic goals.

Patients at PSC Aesthetics begin with in-person consultations at the Wichita facility, where Dr. Sprole or her clinical team conducts medical history reviews, discusses treatment objectives, and determines candidacy for peptide therapy or surgical interventions. For weight loss programs, initial visits include baseline measurements, metabolic panel review, and education on injection technique for self-administration at home between monitoring appointments. The clinic provides detailed instructions on injection site rotation, proper refrigeration of peptide medications, and recognition of adverse effects requiring clinical contact. Patients pursuing both weight management and aesthetic procedures receive coordinated treatment timelines, with peptide therapy often initiated months before planned surgeries to achieve target weight ranges that reduce surgical risk and improve contouring results. Follow-up schedules vary by treatment type, with peptide patients typically seen every four to six weeks during active weight loss phases.

The clinic's location in Wichita serves patients throughout south-central Kansas, with the in-person consultation requirement ensuring direct assessment by Dr. Sprole's team before initiating peptide prescriptions or scheduling procedures. This model prioritizes thorough physical examination and face-to-face discussion of risks, benefits, and alternatives—particularly important for weight loss medications that require cardiovascular screening and monitoring for thyroid-related contraindications. PSC Aesthetics distinguishes itself through the integration of board-certified plastic surgery oversight with medical weight management, allowing patients to address aesthetic concerns with a provider who understands both the metabolic aspects of weight loss and the surgical implications of body composition changes. The clinic's combination of injectable aesthetics, reconstructive surgery, and peptide therapy creates a comprehensive platform for patients seeking coordinated aesthetic and wellness interventions under unified medical direction.